Kanaly Trust’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$6K Hold
252
﹤0.01% 633
2016
Q3
$7K Hold
252
﹤0.01% 598
2016
Q2
$6K Hold
252
﹤0.01% 621
2016
Q1
$8K Hold
252
﹤0.01% 586
2015
Q4
$8K Hold
252
﹤0.01% 600
2015
Q3
$8K Hold
252
﹤0.01% 574
2015
Q2
$12K Sell
252
-10
-4% -$421 ﹤0.01% 529
2015
Q1
$11K Hold
262
﹤0.01% 450
2014
Q4
$7K Hold
262
﹤0.01% 507
2014
Q3
$5K Hold
262
﹤0.01% 551
2014
Q2
$6K Buy
+262
New +$5.31K ﹤0.01% 529

Other funds holding PGEN

Kanaly Trust's PGEN Position: Q4 2016 in Review

Kanaly Trust held its Precigen (PGEN) position steady in Q4 2016 at 252 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #633.

Kanaly Trust first reported a position in PGEN in Q2 2014 and has held it in 11 quarters since. The position peaked at $12K in Q2 2015. 171 funds tracked by Wall St. Rank hold PGEN as of Q4 2016.

  • Kanaly Trust held 252 shares of Precigen worth $6K as of Q4 2016.
  • Kanaly Trust left its Precigen share count unchanged in Q4 2016.
  • Precigen made up ﹤0.01% of Kanaly Trust's portfolio in Q4 2016, its #633 holding.
  • Kanaly Trust first reported a position in Precigen in Q2 2014 and has held it in 11 quarters since.
  • Kanaly Trust's Precigen position peaked at $12K in Q2 2015.
  • 171 funds tracked by Wall St. Rank held Precigen as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.